OakChart

Evolent Health Inc

EVHHealthcare·Health Information Services·USA·Small·NYSE·Nov 11 • 1:05 PM ET

4.86+0.06 (1.35%)
2026-11-11 19:05 CET
Market cap
542.91 USD m
Revenue, TTM
2,342.85 USD m
Net income, TTM
-507.69 USD m
Free cash flow, TTM
36.66 USD m
EPS diluted, TTM
-4.54
P/E
-
Compare

Price

EVH against its 20, 50 and 200-day averages
2050200beatmiss
3.004.005.006.005.6M11.2MMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26EVHclose 4.8720-day 4.6150-day 4.19200-day 3.904.8752w high

22.2% under the 52-week high of 6.26 on 14 Jul 2026. 52-week low 2.10 on 2 Apr 2026. Last 15 sessions, 22.5% high to low

Profile

EVH
52-week range, 66% of the way up
2.106.26

Evolent Health, Inc. engages in the provision of healthcare delivery and payment services. It deals with population health management, health plan and third party administration, network performance and pharmacy benefit management, risk adjustment, analytics and performance improvement, and technology and electronic medical record integration. The company was founded by Frank J. Williams, Seth B. Blackley, and Thomas Peterson III in August 2011 and is headquartered in Arlington, VA.

IndexRUT
Employees4200
IPOJun 05, 2015
Beta1.00
ATR, 14d0.33
Rel volume0.54
Short float10.35%
Insider own9.42%
Inst own88.83%

Snapshot

6 groups

Valuation

IndexRUT
Market Cap550.26M
Enterprise Value1.37B
Income-507.69M
Sales2.34B
Book/sh3.30
Cash/sh1.37
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout-
Employees4200
IPOJun 05, 2015

Ratios

P/E-
Forward P/E13.10
PEG0.17
P/S0.23
P/B1.48
P/C3.56
P/FCF15.01
EV/EBITDA16.88
EV/Sales0.58
Quick Ratio1.26
Current Ratio1.26
Debt/Eq2.61
LT Debt/Eq2.61
Option/ShortYes / Yes

Earnings

EPS (ttm)-4.54
EPS next Y0.37
EPS next Q0.15
EPS this Y123.24%
EPS next Y84.86%
EPS next 5Y75.03%
EPS past 3/5Y-194.21% -5.21%
Sales past 3/5Y11.54% 15.20%
EPS Y/Y TTM-189.46%
Sales Y/Y TTM14.06%
EPS Q/Q11.73%
Sales Q/Q51.27%
EarningsNov 05 BMO
EPS/Sales Surpr.-1.48% -0.23%

Ownership

Insider Own9.42%
Insider Trans-0.61%
Inst Own88.83%
Inst Trans-1.09%
ROA-23.00%
ROE-83.57%
ROIC-37.76%
Gross Margin10.25%
Oper. Margin-1.30%
Profit Margin-21.67%
SMA205.55%
SMA5016.06%
SMA20024.65%
Trades-

Technical

Shs Outstand113.10M
Shs Float102.45M
Short Float10.35%
Short Ratio4.65
Short Interest10.61M
52W High6.26 -22.22%
52W Low2.10 132.22%
Volatility11.43% 7.75%
ATR (14)0.33
RSI (14)60.12
Beta1.00
Rel Volume0.54
Avg Volume2.28M
Volume701,823

Performance

Perf Week1.35%
Perf Month5.76%
Perf Quarter4.40%
Perf Half Y17.80%
Perf YTD21.62%
Perf Year-3.47%
Perf 3Y-82.63%
Perf 5Y-83.03%
Perf 10Y-71.55%
Recom1.43
Target Price5.92
Prev Close4.80
Price4.86
Change %1.35%

Analyst ratings

latest 10 of 20
DateActionAnalystRating changeTargetImplied
Aug 11, 2026UpgradeCCitigroupNeutral → Buy$6+23.3%
Jul 23, 2026DowngradeCCitigroupBuy → Sell$6.75+38.7%
Jun 30, 2026DowngradeTTruistBuy → Hold$7+43.9%
Feb 25, 2026DowngradeKKeyBanc Capital MarketsOverweight → Sector Weight
Nov 13, 2025UpgradeSStephensEqual-Weight → Overweight$7+43.9%
Nov 13, 2025InitiatedBBMO Capital MarketsOutperform$7+43.9%
Jan 10, 2025InitiatedNNeedhamBuy$15+208.3%
Dec 03, 2024ReiteratedBBTIG ResearchBuy$36 → $29+496.1%
Nov 08, 2024DowngradeSStephensOverweight → Equal-Weight$38 → $16+228.9%
Oct 11, 2024InitiatedKKeyBanc Capital MarketsOverweight$35+619.4%

Peers

Mkt cap
TickerCompanyMkt cap
CTEVClaritev Corp502.42M
CICigna Group78.57B
PRVAPrivia Health Group Inc3.07B
HCATHealth Catalyst Inc107.31M
UNHUnitedhealth Group Inc357.71B
HNGEHinge Health Inc9.61B
AGLAgilon Health Inc1.92B
WAYWaystar Holding Corp5.50B
ASTHAstrana Health Inc1.63B
EXLSExlService Holdings Inc6.59B

Insider trading

3 filings
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
McCarthy Daniel JosephPRESIDENTAug 26 '26Sale5.0065,892329,460655,133Aug 28 04:17 PM
Daniel McCarthyOfficerAug 26 '26Proposed Sale4.9765,892327,476Aug 26 05:42 PM
Springstubb Brendan BDirectorNov 18 '25Buy3.8210,00038,19958,821Nov 19 04:23 PM

Held by

AUM
TickerCompanyAUM
IWMiShares Russell 2000 Index FundAUM: 77.38B
VTIVanguard Morningstar Total Stock Market ETFAUM: 687.42B
FNDASchwab Fundamental U.S. Small Company ETFAUM: 8.98B
VXFVanguard Extended Market Index ETFAUM: 30.47B
JSMDJanus Henderson Small/Mid Cap Growth Alpha ETFAUM: 1.04B
IWNiShares Russell 2000 Value ETFAUM: 14.10B
SCHASchwab U.S. Small-Cap ETFAUM: 22.25B
VTWOVanguard Russell 2000 Index ETFAUM: 16.75B
IWOiShares Russell 2000 Growth ETFAUM: 14.06B
PRFZInvesco RAFI US 1500 Small-Mid ETFAUM: 2.66B

News

latest 14 of 206
  • New oncology model from Humana, Evolent and American Oncology Network eliminates prior authorization burden (Business Wire)
  • Evolent Health Narrowly Beats On EPS, But Risk-Based Growth Is Buying Revenue At The Expense Of Margin (Earnings Whispers) -5.42%
  • Evolent Health: Q3 Earnings Snapshot (Associated Press)
  • Evolent Announces Third Quarter 2026 Results (PR Newswire)
  • Evolent's Highmark Ramp Faces Its First Full-Quarter Test As Medical Costs Loom (Earnings Whispers)
  • Loading…
  • Evolent To Release Third Quarter 2026 Financial Results on Thursday, November 5, 2026 (PR Newswire) +5.20%
  • TransPerfect Selected by Evolent for Enterprise-Wide Telephonic Interpretation (PR Newswire)
  • Boeing upgraded, Under Armour downgraded: Wall Street's top analyst calls (The Fly)
  • Evolent Health Inc (EVH) (Q2 2026) Earnings Call Highlights: Revenue Surges 31% and Guidance ... (GuruFocus.com) +16.56%
  • Evolent Health: Q2 Earnings Snapshot (Associated Press)
  • Evolent Announces Second Quarter 2026 Results (PR Newswire)
  • Forget Nvidia. These 5 S&P 500 stocks are quietly going all in on AI. (MarketWatch)
  • Evolent To Release Second Quarter 2026 Financial Results on Thursday, August 6, 2026 (PR Newswire)

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q32026-11-050.0600.061-0.210725.37727.069
2026Q22026-08-060.020-0.010-0.252652.52597.6910
2026Q12026-05-07-0.020-0.049-0.238496.2553413
2025Q42026-02-240.0800.051-3.845468.72468.6613
2025Q32025-11-060.0500.098-0.236479.53468.1711
2025Q22025-08-07-0.1000.074-0.441444.33459.0311
2025Q12025-05-080.0600.094-0.627483.65460.7210
2024Q42025-02-20-0.0200.030-0.266646.54651.3110
2024Q32024-11-070.0400.310-0.272621.4627.1714
2024Q22024-08-080.3000.239-0.056647.15636.7512
2024Q12024-05-090.3400.218-0.221639.65600.8312
2023Q42024-02-220.2300.167-0.364556.06542.458
2023Q32023-11-020.3000.103-0.296511.02509.386
2023Q22023-08-020.1400.155-0.372469.14460.717
2023Q12023-05-030.2100.171-0.244427.69434.358
2022Q42023-02-220.1000.098-0.114382.43372.936

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2019FY-0.720-0.691-3.666846.38844.15
2020FY-0.210-0.243-3.9361,0221,012
2021FY0.020-0.037-0.358907.96890.15
2022FY0.9500.861-0.1991,3521,343
2023FY0.8700.783-1.2791,9641,950
2024FY0.4100.707-0.8152,5552,559
2025FY0.0900.064-5.0701,8761,876
2026FY-0.201--2,641
2027FY-0.371--3,308
2028FY-0.483--3,662
2029FY-0.710--4,180
2030FY-0.930--4,586

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q4S2026-11-061451766.31727.2808.73
2026Q4S2026-11-051441764.57727.2799.5
2026Q4S2026-10-281400759.46725.01799.5
2026Q4S2026-10-251420759.46725.01799.5
2026Q4S2026-10-241430759.46725.01799.5
2026Q4S2026-10-201440759.46725.01799.5
2026Q4S2026-10-0514121759.46725.01799.5
2026Q4S2026-09-2514121759.46725.01799.5
2026Q4S2026-09-1715131758.81725.01799.5
2026Q4S2026-08-1715141758.81725.01799.5
2026Q4S2026-08-1415141758.79725.01799.5
2026Q4S2026-08-1115131753.55700799.5
2026Q4S2026-08-1015131751.44700799.5
2026Q4S2026-08-0715111747.5699.3799.5

Estimate history

EPS, annual-0.94-0.681-3.666-3.936-0.358-0.199-1.279-0.815-5.073-4.5433
Period201720182019202020212022202320242025TTM
EPS, quarterly-0.272-0.266-0.627-0.441-0.236-3.845-0.238-0.252-0.208
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Sales, annual434.95627.063846.383924.639907.9571352.0131963.8962554.7411876.2292342.85
Period201720182019202020212022202320242025TTM
Sales, quarterly621.401646.542483.649444.328479.533468.719496.246652.52725.367
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Shares, annual74.72479.17284.58984.35789.22199.963113.887115.038111.632113.101
Period201720182019202020212022202320242025MRQ
Shares, quarterly115.013115.038115.86115.935111.593111.632112.478112.685113.101
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Total Revenue2,342.851,876.232,554.741,963.901,352.01907.96924.64846.38627.06
Cost of Goods Sold Incl. D&A2,102.821,592.202,306.861,626.841,105.62717.59757.42710.75372.34
Gross Profit240.03284.03247.88337.06246.39190.37167.22135.64254.72
Selling, General and Administrative Excl. Other270.57288.47245.55306.27241.33207.79198.03238.65231.02
Research and Development-----15.5015.1019.8018.20
Other Operating Expense0.000.000.000.000.000.000.000.000.00
Operating Income-30.53-4.432.3330.785.06-17.42-30.81-103.0123.70
Interest Expense69.7357.4724.7254.2015.5725.4328.3214.535.48
Unusual Expense423.63439.8642.99176.8857.5646.33283.26213.2071.19
Net Income Before Taxes-504.63-534.64-63.04-202.41-62.08-29.80-330.54-327.12-54.15
Income Taxes3.07-0.13-1.41-89.36-43.380.48-2.37-21.540.04
Consolidated Net Income-507.69-534.51-61.62-113.04-18.70-30.28-328.17-305.58-54.19
Net Income From Continuing Operations-507.69-534.51-61.62-113.04-18.70-30.28-328.17-301.97-52.66
Net Income-507.69-579.40-93.45-142.26-18.66-30.80-334.25-301.97-52.66
EPS (Recurring)-1.87-2.38-0.55-0.170.230.02-1.60-1.85-0.04
EPS (Basic, Before Extraordinaries)-4.54-5.07-0.81-1.28-0.20-0.36-3.94-3.67-0.68
EPS (Diluted)-4.54-5.07-0.81-1.28-0.20-0.36-3.94-3.67-0.68
EBITDA81.06111.42125.50154.2095.3142.6230.02-36.3768.22
Non-Operating Income (Expense)19.27-32.872.34-2.106.0059.3811.863.63-1.19
Other After Tax Adjustments0.000.000.000.000.000.000.000.000.00
Stock Option Compensation Expense34.0131.3931.4032.0026.8412.2010.6611.4013.91
Price To Sales Ratio0.170.240.511.871.952.621.470.882.46
Gross Margin10.2515.149.7017.1618.2220.9718.0916.0340.62
Operating Margin-1.30-0.240.091.570.37-1.92-3.33-12.173.78
Net Margin-21.67-30.88-3.66-7.24-1.38-3.39-36.15-35.68-8.40
Shares Outstanding113.10111.63115.04113.8999.9689.2284.3684.5979.17
Market Capitalization542.91542.911,311.353,797.132,841.442,473.991,375.03759.331,562.90

Income statement, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q22025Q12024Q4
Total Revenue725.37652.52496.25468.72479.53444.33483.65646.54
Cost of Goods Sold Incl. D&A658.74593.25434.33416.50403.67367.38405.44600.13
Gross Profit66.6359.2761.9252.2275.8676.9478.2146.41
Selling, General and Administrative Excl. Other68.6767.9972.0661.8675.2074.1276.5147.00
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income-2.04-8.72-10.14-9.640.662.831.70-0.58
Interest Expense17.0016.8616.8719.0116.4811.6010.386.72
Unusual Expense4.150.840.46418.185.3413.003.3318.01
Net Income Before Taxes-22.45-25.65-25.72-430.81-19.96-20.72-63.15-23.92
Income Taxes1.122.710.91-1.680.91-0.821.47-1.12
Consolidated Net Income-23.57-28.36-26.63-429.13-20.86-19.90-64.62-22.80
Net Income From Continuing Operations-23.57-28.36-26.63-429.13-20.86-19.90-64.62-22.80
Net Income-23.57-28.36-26.63-429.13-26.93-51.09-72.25-30.61
EPS (Recurring)-0.18-0.25-0.24-1.22-0.20-0.36-0.61-0.16
EPS (Basic, Before Extraordinaries)-0.21-0.25-0.24-3.84-0.24-0.44-0.63-0.27
EPS (Diluted)-0.21-0.25-0.24-3.84-0.24-0.44-0.63-0.27
EBITDA20.4612.8512.3535.4027.4527.2527.0029.91
Non-Operating Income (Expense)0.740.771.7516.021.201.05-51.141.39
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense11.7012.018.411.8911.609.158.754.83
Price To Sales Ratio0.170.290.140.240.470.590.460.51
Gross Margin9.199.0812.4811.1415.8217.3216.177.18
Operating Margin-0.28-1.34-2.04-2.060.140.640.35-0.09
Net Margin-3.25-4.35-5.37-91.55-5.62-11.50-14.94-4.74
Shares Outstanding113.10112.68112.48111.63111.59115.94115.86115.04
Market Capitalization542.91609.65254.53446.40994.131,321.921,104.121,311.35

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY
Cash & Short Term Investments177.99163.50206.59202.69341.96333.38122.89383.04300.83
Short Term Receivables309.86414.68463.15254.68130.60124.3977.4282.3168.95
Inventories0.000.000.000.000.000.000.000.000.00
Other Current Assets18.5228.9413.9320.6851.3989.8828.4922.628.40
Total Current Assets506.37607.12683.67478.05523.96547.65228.80487.97378.18
Net Property, Plant & Equipment85.1679.2890.18136.90131.57144.04157.3373.6350.92
Total Investments and Advances11.6723.5921.7616.9418.4313.15147.6322.394.82
Long-Term Note Receivable---0.004.884.551.00--
Intangible Assets1,279.421,817.481,868.551,165.56706.08614.02880.521,103.16869.45
Deferred Tax Assets2.03----102.74123.05--
Other Assets14.5816.9516.1519.8434.5448.2882.7335.149.33
Total Assets1,899.242,544.412,680.311,817.291,419.461,474.441,621.061,722.281,312.70
Short Term Debt Incl. Current Port. of LT Debt15.34198.189.747.127.0733.916.270.000.00
Accounts Payable59.7896.0348.2557.1796.0831.9837.49146.7642.93
Other Current Liabilities310.14421.29616.26369.15342.34337.40149.01122.6089.77
Total Current Liabilities385.26715.50674.24433.44445.49403.29192.77269.36132.70
Long Term Debt974.36705.66813.49469.00273.40325.87362.52221.04121.39
Provision for Risks Charges0.000.000.000.000.000.000.000.000.00
Deferred Tax Liabilities7.5110.9013.314.741.40103.42124.9925.442.44
Other Liabilities116.92111.09111.5750.695.5322.2611.7317.099.86
Total Liabilities1,484.041,543.151,612.61957.88725.83854.84692.02532.92266.39
Non-Equity Reserves0.000.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.000.00
Common Equity415.191,001.261,067.70859.42693.63619.60922.361,143.821,010.88
Total Shareholders Equity415.191,001.261,067.70859.42693.63619.60922.361,143.821,010.88
Accumulated Minority Interest0.000.000.000.000.000.006.6945.5335.43
Total Equity415.191,001.261,067.70859.42693.63619.60929.051,189.361,046.31
Total Liabilities & Stockholders Equity1,899.242,544.412,680.311,817.291,419.461,474.441,621.061,722.281,312.70
Book Value Per Share3.728.709.388.607.777.3410.9014.4513.53
Tangible Book Value Per Share-7.74-7.10-7.03-3.06-0.140.070.490.511.89
Full-Time Employees4,2004,5004,7005,1003,5002,9003,4003,8002,600
Price to Book Ratio1.461.253.413.273.562.180.831.380.90
Return on Assets-24.06-2.36-5.03-1.16-2.09-21.20-18.06-3.47-4.83
Return on Equity-75.47-5.96-11.73-2.41-4.61-42.57-29.23-4.89-7.08
Return on Invested Capital-38.47-3.61-6.01-1.40-3.19-35.35-23.50-3.86-5.36
Quick Ratio1.310.851.011.101.181.361.191.812.85
Current Ratio1.310.851.011.101.181.361.191.812.85

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Net Income-507.69-534.51-61.62-113.04-19.16-37.60-334.25-305.58-54.19
Depreciation109.65115.85118.37123.4267.1960.0461.4860.9144.52
Other Funds (Non Cash)453.91517.8781.56188.2090.4730.48313.00224.8123.85
Funds from Operations56.6096.23135.32105.3292.8952.3939.09-42.9814.21
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital8.28-57.38-116.5637.27-104.44-13.64-55.320.33-34.87
Cash from Operating Activities64.8838.8418.77142.58-11.5538.75-16.23-42.65-20.65
Capital Expenditures-28.23-34.09-24.89-28.75-47.52-24.98-31.76-35.53-39.55
Net Assets From Acquisitions-1.40-57.44-30.73-388.25-248.11-49.01-0.30-8.57-130.24
Sale of Fixed Assets and Businesses0.000.000.000.000.000.000.000.000.50
Purchase or Sale of Investments0.30-0.01-7.310.875.5511.72132.27-96.53-11.08
Purchase of Investments0.00-1.00-7.320.000.00-3.00-11.17-99.10-19.37
Sale Or Maturity of Investments0.300.990.010.875.5514.72143.442.588.29
Other Uses0.000.000.000.000.000.000.00-46.400.00
Other Sources91.3191.310.000.5830.9746.49160.865.4020.00
Cash from Investing Activities61.99-0.23-62.93-415.54-259.12-15.79261.07-181.63-160.38
Cash Dividends Paid0.00-11.13-20.09-18.79-14.88-1.30-20.000.000.00
Change in Capital Stock0.00-40.003.46180.524.4513.292.581.0911.93
Repurchase of Common Pref Stock0.00-40.000.000.000.000.000.000.000.00
Sale of Common Pref Stock0.000.003.46180.524.4513.292.581.0911.93
Proceedsfrom Stock Options0.000.000.00168.000.000.000.000.000.00
Issuance or Reduction of Debt, Net-105.4265.0658.58183.29219.74-0.4313.4662.65167.18
Change in Long Term Debt-105.4265.0658.58183.29219.74-0.4313.4662.65167.18
Issuance of Long Term Debt18.31408.0558.58647.49219.740.0030.0662.65167.18
Reduction of Long Term Debt-123.73-342.980.00-464.200.00-0.43-16.610.000.00
Net Financing Active Other Cash Flow-7.13-49.86-42.52-63.68-77.77-41.11-7.89-99.2894.92
Other Financing Activities Uses-7.13-49.86-86.05-63.68-77.77-102.27-7.89-106.88-1.24
Cash from Financing Activities-112.55-35.92-0.56281.34131.54-29.55-11.86-35.55274.02
Exchange Rate Effect-1.47-0.49-0.23-0.08-0.66-0.050.070.03-0.04
Net Change in Cash12.852.20-44.968.30-139.78-6.64233.05-259.7992.96
Free Cash Flow36.664.75-6.13113.84-49.9113.76-45.70-78.18-60.20
Preferred Dividends (Cash Flow)--11.13-20.09-18.790.000.000.000.000.00
Price to Free Cash Flow10.77--38.66-191.07---
Deferred Taxes & Investment Tax Credit--2.98-2.99-93.25-45.61-0.53-1.13-23.120.04

Balance sheet, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Cash & Short Term Investments154.78138.69166.00177.99140.34175.36
Short Term Receivables442.77449.12314.16309.86386.56358.76
Inventories0.000.000.000.000.000.00
Other Current Assets19.5722.7021.8518.5243.1928.14
Total Current Assets617.12610.51502.01506.37570.09562.26
Net Property, Plant & Equipment85.0784.6385.0585.1684.9282.61
Total Investments and Advances9.7411.5411.6911.6711.6011.59
Intangible Assets1,233.591,248.861,264.121,279.421,699.071,788.49
Deferred Tax Assets---2.03--
Other Assets16.6416.3615.9814.5887.7716.59
Total Assets1,962.161,971.891,878.851,899.242,453.462,461.53
Short Term Debt Incl. Current Port. of LT Debt1.321.548.7815.3423.06196.33
Accounts Payable37.8438.8263.0159.7872.1869.46
Other Current Liabilities450.77452.47309.45310.14334.69291.73
Total Current Liabilities489.94492.83381.24385.26429.93557.52
Long Term Debt971.73968.89976.65974.361,059.26885.67
Provision for Risks Charges0.000.000.000.000.000.00
Deferred Tax Liabilities10.649.947.577.5110.1510.45
Other Liabilities117.00117.00117.00116.92111.89111.89
Total Liabilities1,589.311,588.671,482.451,484.041,611.231,565.53
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity372.85383.22396.39415.19842.23896.00
Total Shareholders Equity372.85383.22396.39415.19842.23896.00
Accumulated Minority Interest0.000.000.000.000.000.00
Total Equity372.85383.22396.39415.19842.23896.00
Total Liabilities & Stockholders Equity1,962.161,971.891,878.851,899.242,453.462,461.53
Book Value Per Share3.303.403.523.727.557.73
Tangible Book Value Per Share-7.61-7.68-7.71-7.74-7.68-7.70
Full-Time Employees---4,200--
Price to Book Ratio1.461.540.610.531.091.39
Return on Assets-23.00-22.78-21.91-24.06-5.17-5.29
Return on Equity-83.57-78.95-74.56-75.47-13.63-13.38
Return on Invested Capital-1.75-2.10-1.94-30.88-1.10-1.12
Quick Ratio1.261.241.321.311.331.01
Current Ratio1.261.241.321.311.331.01

Cash flow, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Net Income-23.57-28.36-26.63-429.13-20.86-19.90
Depreciation21.4921.5721.5545.0423.6123.14
Other Funds (Non Cash)18.9220.4715.05399.4723.8226.70
Funds from Operations17.6516.0710.5512.3427.2029.08
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital8.73-25.38-11.5336.46-11.39-59.41
Cash from Operating Activities26.38-9.31-0.9848.8015.81-30.33
Capital Expenditures-7.21-6.85-6.41-7.76-8.96-8.77
Net Assets From Acquisitions0.000.000.00-1.400.00-51.55
Sale of Fixed Assets and Businesses0.000.000.000.000.000.00
Purchase or Sale of Investments0.150.150.000.000.20-0.21
Purchase of Investments0.000.000.000.000.00-1.00
Sale Or Maturity of Investments0.150.150.000.000.200.79
Other Uses0.000.000.000.000.000.00
Other Sources0.000.000.0091.310.000.00
Cash from Investing Activities-7.06-6.70-6.4182.15-8.76-60.53
Cash Dividends Paid0.000.000.000.00-1.93-4.62
Preferred Dividends (Cash Flow)0.000.000.000.00-1.93-4.62
Change in Capital Stock0.000.000.000.00-40.000.00
Repurchase of Common Pref Stock0.000.000.000.00-40.000.00
Sale of Common Pref Stock0.000.000.000.000.000.00
Proceedsfrom Stock Options0.000.000.000.000.000.00
Issuance or Reduction of Debt, Net0.00-10.000.00-95.421.990.00
Change in Long Term Debt0.00-10.000.00-95.421.990.00
Issuance of Long Term Debt0.000.000.0018.31168.740.00
Reduction of Long Term Debt0.00-10.000.00-113.73-166.750.00
Net Financing Active Other Cash Flow-4.55-0.99-3.972.39-1.88-4.31
Other Financing Activities Uses-4.55-0.99-3.972.39-1.88-4.31
Cash from Financing Activities-4.55-10.99-3.97-93.04-41.81-8.93
Exchange Rate Effect-0.38-0.27-0.59-0.23-0.20-0.08
Net Change in Cash14.39-27.28-11.9537.69-34.97-99.88
Free Cash Flow19.17-16.16-7.3941.046.85-39.10
Price to Free Cash Flow10.7727.22----

Revenue breakdown

Administrative Service2024: 238.04M
Cases2024: 176.52M
Performance Suite2024: 1.80B
Specialty Technology And Services Suite2024: 338.31M
Total Services-Management Services revenue2025: 1.88B
United States2024: 2.55B 2025: 1.88B
Total Services-Management Services revenue2024: 2.55B 2025: 1.88B

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-3010.35%10.6M102.5M2.52M
2026-10-1511.62%11.9M102.4M3.00M
2026-09-3012.60%12.9M102.4M3.03M
2026-09-1513.74%14.1M102.4M3.09M
2026-08-3115.11%15.5M102.4M3.11M
2026-08-1415.41%15.8M102.3M3.07M
2026-07-3114.61%15.8M108.2M2.92M
2026-07-1513.64%14.7M107.7M2.56M
2026-06-3014.78%15.8M107.1M2.72M
2026-06-1513.61%14.6M107.1M2.78M
2026-05-2913.76%14.8M107.5M2.89M
2026-05-1514.70%14.9M101.6M3.12M
2026-04-3014.98%15.4M102.8M3.14M
2026-04-1515.88%16.2M102.0M3.31M
2026-03-3115.57%16.0M102.5M3.19M
2026-03-1317.71%18.1M102.5M3.16M
2026-02-2717.89%18.3M102.5M3.17M
2026-02-1319.73%20.2M102.4M3.38M
2026-01-3018.75%19.2M102.4M3.85M
2026-01-1518.68%19.1M102.4M3.61M

Option chain

expiry 2026-11-20
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call2.502.202.702.375.1664800.000.884-0.0490.002
call5.000.100.250.150.9703030.000.480-0.0180.003
call7.500.000.050.011.7971.000.000.086-0.0110.001
call10.000.000.700.002.6520.000.000.065-0.0140.001
put2.500.000.750.015.7832.000.00-0.117-0.0480.002
put5.000.250.400.501.1177270.00-0.520-0.0170.003
put7.502.303.303.894.3901.000.00-0.913-0.0120.001
put10.004.805.800.005.5220.000.00-0.935-0.0130.001

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-058-KCurrent report2026-11-05SEC
2026-11-0510-QQuarterly report pursuant to Section 13 or 15(d)2026-09-30SEC
2026-09-08SCHEDULE 13G/ASEC
2026-08-284Statement of changes in beneficial ownership of securities2026-08-26SEC
2026-08-26144Filing for proposed sale of securities under Rule 144.SEC
2026-08-0610-QQuarterly report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-08-068-KCurrent report2026-08-06SEC
2026-07-17SCHEDULE 13GSEC
2026-07-064Statement of changes in beneficial ownership of securities2026-07-01SEC
2026-07-064Statement of changes in beneficial ownership of securities2026-07-01SEC
2026-07-064Statement of changes in beneficial ownership of securities2026-07-01SEC
2026-07-064Statement of changes in beneficial ownership of securities2026-07-01SEC
2026-06-10S-8Initial registration statement for securities to be offered to employees pursuant to employee benefit plansSEC
2026-06-084Statement of changes in beneficial ownership of securities2026-06-04SEC
2026-06-084Statement of changes in beneficial ownership of securities2026-06-04SEC
2026-06-084Statement of changes in beneficial ownership of securities2026-06-04SEC
2026-06-084Statement of changes in beneficial ownership of securities2026-06-04SEC
2026-06-084Statement of changes in beneficial ownership of securities2026-06-04SEC
2026-06-084Statement of changes in beneficial ownership of securities2026-06-04SEC
2026-06-084Statement of changes in beneficial ownership of securities2026-06-04SEC
2026-06-084Statement of changes in beneficial ownership of securities2026-06-04SEC
2026-06-084Statement of changes in beneficial ownership of securities2026-06-04SEC
2026-06-048-KCurrent report2026-06-04SEC
2026-05-0710-QQuarterly report pursuant to Section 13 or 15(d)2026-03-31SEC
2026-05-078-KCurrent report2026-05-07SEC
2026-04-24ARSAnnual report to security holders. 2025-12-31SEC
2026-04-24DEFA14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934SEC
2026-04-24DEF 14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 19342026-06-04SEC
2026-03-26SCHEDULE 13G/ASEC
2026-03-044Statement of changes in beneficial ownership of securities2026-03-01SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-090000
2026-0800329.46K1
2026-070000
2026-060000
2026-050000
2026-040000
2026-030000
2026-020000
2026-010000
2025-120000
2025-1138.20K100

Institutional holders

Manager% owned
BlackRock, Inc.13.17%
CADIAN CAPITAL MANAGEMENT, LP9.61%
Ewing Morris & Co. Investment Partners Ltd.9.33%
MORGAN STANLEY7.97%
Rubicon Founders LLC5.17%
Engaged Capital LLC4.95%
D. E. Shaw & Co., Inc.4.54%
VANGUARD CAPITAL MANAGEMENT LLC4.26%
Nuveen, LLC3.45%
MARSHALL WACE, LLP3.03%

Funds

Fund% owned
iShares Convertible Bond ETF6.73%
Columbia Convertible Securities Fund6.19%
State Street(R) SPDR(R) Bloomberg Convertible Securities ETF4.99%
VANGUARD TOTAL STOCK MARKET INDEX FUND3.01%
Fidelity Convertible Securities Fund2.79%
iShares Russell 2000 ETF2.62%
BlackRock Advantage Small Cap Core Fund1.29%
Nuveen Quant Small Cap Equity Fund1.26%
VANGUARD EXTENDED MARKET INDEX FUND1.16%
Fidelity Small Cap Index Fund1.11%

OakChart. EVH. Cached 15 minutes.